NCT01221558

Brief Summary

The hypothesis was that an increase in serum lycopene levels following supplementation with capsules containing natural lycopene rich tomato extract would reduce oxidative stress and improve endothelial function in healthy men with low intake of fruits and vegetables. A randomized double-blind, placebo-controlled study was designed to assess the changes in serum lycopene levels, oxidative stress and endothelial function in response to an 8-week treatment with lycopene supplementation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jul 2009

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 13, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 15, 2010

Completed
Last Updated

October 15, 2010

Status Verified

June 1, 2009

Enrollment Period

9 months

First QC Date

October 13, 2010

Last Update Submit

October 14, 2010

Conditions

Outcome Measures

Primary Outcomes (4)

  • lymphocyte DNA damage

    8 weeks

  • antioxidant enzymes : SOD, GSH-Px, Catalase

    8 weeks

  • lipid peroxidation marker : MDA, urinary 8 epi-PGF 2alpha

    8 weeks

  • oxidized LDL

    8 weeks

Secondary Outcomes (4)

  • Reactive hyperemia peripheral arterial tonometry (RH-PAT) index

    8 weeks

  • VCAM-1/ICAM-1

    8 weeks

  • cytokines : IL-6, TNF-alpha, IL-1beta

    8 weeks

  • hs-CRP

    8 weeks

Study Arms (3)

6mg lycopene

EXPERIMENTAL
Dietary Supplement: lycopene

15mg lycopene

EXPERIMENTAL
Dietary Supplement: lycopene

placebo

PLACEBO COMPARATOR
Dietary Supplement: lycopene

Interventions

lycopeneDIETARY_SUPPLEMENT
15mg lycopene6mg lycopeneplacebo

Eligibility Criteria

Age20 Years - 60 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy men who frequently smoked cigarettes or consumed alcohol

You may not qualify if:

  • consumption of more than 3 servings/day of vegetables and fruit, or more than one serving/week of lycopene-rich foods
  • taking antioxidant, vitamin, or mineral supplements
  • any history of chronic disease (diabetes, heart disease, renal disease)
  • taking lipid-lowering or antihypertensive medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University.

Seoul, 120-749, South Korea

Location

MeSH Terms

Interventions

Lycopene

Intervention Hierarchy (Ancestors)

CarotenoidsPolyenesAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsCyclohexenesCyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicTerpenesPigments, BiologicalBiological Factors

Study Officials

  • Jong Ho Lee, Ph.D.

    Yonsei University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 13, 2010

First Posted

October 15, 2010

Study Start

July 1, 2009

Primary Completion

April 1, 2010

Study Completion

September 1, 2010

Last Updated

October 15, 2010

Record last verified: 2009-06

Locations